Healthcare Realty Trust Inc (HR) 35.43 $HR Uptrend Call

New Post Public Reply Private Reply Replies (0) Message Board

Sep 5, 2016 at 11:10 AM

Healthcare Realty Trust Inc (HR) 35.43 $HR

Uptrend Call Working As Healthcare Realty Trust Stock Rises 31.2% (HR)
Comtex SmarTrend(R) - Wed Aug 31, 12:46AM CDT
SmarTrend identified an Uptrend for Healthcare Realty Trust (NYSE:HR) on November 25th, 2015 at $26.83. In approximately 9 months, Healthcare Realty Trust has returned 31.22% as of today's recent price of $35.20.
HR: 35.43 (+0.45)

Healthcare Realty Trust Has Returned 31.7% Since SmarTrend Recommendation (HR)
Comtex SmarTrend(R) - Tue Aug 23, 1:13PM CDT
SmarTrend identified an Uptrend for Healthcare Realty Trust (NYSE:HR) on November 25th, 2015 at $26.83. In approximately 9 months, Healthcare Realty Trust has returned 31.74% as of today's recent price of $35.34.
HR: 35.43 (+0.45)

October 21st Options Now Available For Healthcare Realty Trust (HR)
DividendChannel.com - Mon Aug 22, 9:33AM CDT
Investors in Healthcare Realty Trust, Inc. saw new options begin trading today, for the October 21st expiration.
HR: 35.43 (+0.45)

31.3% Return Seen to Date on SmarTrend Healthcare Realty Trust Call (HR)
Comtex SmarTrend(R) - Tue Aug 16, 12:38AM CDT
SmarTrend identified an Uptrend for Healthcare Realty Trust (NYSE:HR) on November 25th, 2015 at $26.83. In approximately 9 months, Healthcare Realty Trust has returned 31.33% as of today's recent price of $35.23.
HR: 35.43 (+0.45)

Healthcare Realty (HR) Q2 FFO In Line, Revenues Surpass
Zacks Equity Research - Zacks Investment Research - Thu Aug 04, 10:23AM CDT
Healthcare Realty Trust Inc. (HR) reported second-quarter 2016 normalized funds from operations of 42 cents per share, in line with the Zacks Consensus Estimate.
WPC: 66.52 (+0.68), HR: 35.43 (+0.45), COR: 79.59 (+0.84), CLI: 28.52 (+0.68)

Healthcare Realty Trust Reports Normalized FFO of $0.42 Per Share for the Second Quarter
GlobeNewswire - Wed Aug 03, 4:02PM CDT
Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2016. Normalized FFO for the three months ended June 30, 2016 totaled $0.42 per diluted common share. Revenue for the second quarter grew by $5.9 million to $102.6 million compared to the same quarter in 2015. The Company reported net income of $12.1 million or $0.12 per share for the quarter.
HR: 35.43 (+0.45)

Healthcare Realty Trust Announces Second Quarter Dividend
GlobeNewswire - Tue Aug 02, 1:34PM CDT
Healthcare Realty Trust Incorporated (NYSE:HR) today announced its common stock cash dividend for the quarter ended June 30, 2016. This dividend, in the amount of $0.30 per share, is payable on August 31, 2016 to shareholders of record on August 17, 2016.
HR: 35.43 (+0.45)

Healthcare Realty Trust Up 36.0% Since SmarTrend Uptrend Call (HR)
Comtex SmarTrend(R) - Fri Jul 29, 1:03PM CDT
SmarTrend identified an Uptrend for Healthcare Realty Trust (NYSE:HR) on November 25th, 2015 at $26.83. In approximately 8 months, Healthcare Realty Trust has returned 35.96% as of today's recent price of $36.47.
HR: 35.43 (+0.45)

Watch for Healthcare Realty Trust to Potentially Rebound After Falling 1.19% Yesterday
Comtex SmarTrend(R) - Wed Jun 22, 3:43PM CDT
Healthcare Realty Trust (NYSE:HR) traded in a range yesterday that spanned from a low of $33.11 to a high of $33.41. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $33.28 on volume of 243,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HR: 35.43 (+0.45)

Technical Briefing on REIT - Healthcare Facilities Stocks - Ventas, Welltower, Senior Housing Properties Trust, and Healthcare Realty Trust
PR Newswire - Fri Jun 17, 7:35AM CDT
On Thursday, June 16, 2016, the NASDAQ Composite ended the trading session at 4,844.92, up 0.21%; the Dow Jones Industrial Average advanced 0.53% to finish at 17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Ventas Inc. (NYSE: VTR), Welltower Inc. (NYSE: HCN), Senior Housing Properties Trust (NYSE: SNH), and Healthcare Realty Trust Inc. (NYSE: HR). Learn more about these stocks by accessing their free trade alerts at:
HCN: 76.70 (+0.27), HR: 35.43 (+0.45), SNH: 22.92 (+0.45), VTR: 73.41 (+1.08)

Will Healthcare Realty (HR) Stock Rise on In-Line Q1 FFO?
Zacks Equity Research - Zacks Investment Research - Thu May 05, 7:38AM CDT
Healthcare Realty Trust Inc. (HR) reported first-quarter 2016 normalized funds from operations of 41 cents per share that came in line with the Zacks Consensus Estimate.
HR: 35.43 (+0.45), PSA: 226.79 (+0.68), COR: 79.59 (+0.84), NHI: 80.67 (+0.88)

Healthcare Realty Trust Reports Normalized FFO of $0.41 Per Share for the First Quarter
GlobeNewswire - Wed May 04, 4:00PM CDT
Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the first quarter ended March 31, 2016. Normalized FFO for the three months ended March 31, 2016 totaled $0.41 per diluted common share. Revenue for the first quarter grew by $3.6 million to $100.0 million compared to the same quarter in 2015. The Company reported net income of $9.2 million for the quarter.
HR: 35.43 (+0.45)

Healthcare Realty Trust Announces First Quarter Dividend
GlobeNewswire - Tue May 03, 1:32PM CDT
Healthcare Realty Trust Incorporated (NYSE:HR) today announced its common stock cash dividend for the quarter ended March 31, 2016. This dividend, in the amount of $0.30 per share, is payable on May 31, 2016 to shareholders of record on May 16, 2016.
HR: 35.43 (+0.45)

Fitch Affirms Healthcare Realty Trust at 'BBB'; Outlook Stable
BusinessWire - Fri Apr 15, 1:09PM CDT
Fitch Ratings has affirmed the ratings of Healthcare Realty Trust (NYSE: HR) including the Issuer Default Rating (IDR) at 'BBB'. The Rating Outlook remains Stable. A full list of rating actions follows at the end of this release.
HR: 35.43 (+0.45)

Healthcare Realty Trust Announces First Quarter Earnings Release Date And Conference Call
PR Newswire - Tue Apr 05, 4:01PM CDT
Healthcare Realty Trust Incorporated (NYSE: HR) today announced that on Wednesday evening, May 4, 2016, after the market closes, it expects to report results for the first quarter of 2016.
HR: 35.43 (+0.45)

Highwoods (HIW) Q4 FFO Beats Estimates, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 10:50AM CST
Highwoods Properties Inc. (HIW) reported fourth-quarter 2015 funds from operations of 82 cents per share, which beat the Zacks Consensus Estimate by a penny.
VNO: 103.74 (+0.79), HR: 35.43 (+0.45), PSB: 113.13 (+2.42), HIW: 53.53 (+0.47)

Federal Realty Q4 FFO Misses Estimates, Revenues Improve
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 10:30AM CST
Federal Realty Investment Trust (FRT) posted fourth-quarter 2015 funds from operations per share of $1.37, which missed the Zacks Consensus Estimate by a penny.
VNO: 103.74 (+0.79), HR: 35.43 (+0.45), PSB: 113.13 (+2.42), FRT: 159.48 (+1.41)

HCP Inc. Q4 FFO Beats Estimates, Revenues Improve
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:36AM CST
HCP reported fourth-quarter 2015 adjusted funds from operations per share of 80 cents, beating the Zacks Consensus Estimate by 2 cents and up a penny year over year.
VNO: 103.74 (+0.79), HCP: 39.08 (+0.28), HR: 35.43 (+0.45), PSB: 113.13 (+2.42)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's CagriSema Trials Show Promising Weight Loss

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...